Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.
Sec. Clinical Nutrition
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1464414

Association of inflammation and nutrition status with all-cause and cardiov ascular mortality in individuals with osteoarthritis: NHANES, 1999-2018

Provisionally accepted
Qifang Guo Qifang Guo Yijia Shao Yijia Shao Fei Wang Fei Wang Wei Zhou Wei Zhou Xinwang Duan Xinwang Duan *
  • Second Affiliated Hospital of Nanchang University, Nanchang, China

The final, formatted version of the article will be published soon.

    Background Osteoarthritis (OA) is the most prevalent form of arthritis worldwide. Inflammation and nutrition status play crucial roles in the development and progression of OA. The study aimed to investigate the associations of the advanced lung cancer inflammation index(ALI) and advanced lung cancer inflammation index(SII) with all-cause and cardiovascular mortality among US adults with OA. Methods A total of 2602 individuals aged 20 years and above with OA were included in the study from the National Health and Nutrition Examination Survey(NHANES) spanning from 1999 to 2018. Participants were categorized into higher or lower ALI and SII groups using cut-off values determined by the maximally selected rank statistics method. The Kaplan-Meier analysis, Cox proportional hazards models, and Fine Gray competing risk regression models were employed to assess the associations between the ALI/SII and mortality in OA patients. Additionally, stratified and subgroup analyses were conducted to enhance the robustness of the findings. Furthermore, time-dependent receiver operating characteristic (ROC) analysis was used to evaluate the predictive capacity of ALI and SII for mortality. Results Higher SII levels were associated with a twofold increase in the risk of all-cause mortality(HR: 2.00, 95% CI: 1.59-2.52, p<0.001), whereas individuals with higher ALI in the OA group exhibited a significantly reduced risk of all-cause mortality(HR: 0.49, 95% CI: 0.39–0.60, p < 0.001). Notably, in Model 3, individuals with higher ALI demonstrated a substantially lower risk of cardiovascular mortality (HR: 0.60, 95% CI: 0.44–0.82, p < 0.001). Conversely, in fully adjusted models, those with higher SII experienced a significantly higher risk (HR: 1.83, 95% CI: 1.29–2.60, p < 0.001). The RCS analysis revealed a J-shaped non-linear relationship between SII levels and all-cause mortality (p overall < 0.001; p nonlinear < 0.001), and an L-shaped non-linear association between ALI levels and all-cause mortality (p overall < 0.001; p nonlinear = 0.002). The time-dependent ROC curves illustrated that ALI and SII displayed a reasonably good and consistent predictive performance for both short- and long-term mortality in OA patients. Conclusions Lower ALI and higher SII values were correlated with increased risks of all-cause and cardiovascular mortality among US adults with OA.

    Keywords: systemic immune i nflammation index (SII), advanced lung cancer inflammation index (ALI), Mortality, Osteoarthritis, National Health and Nutrition Examination Survey (NHANES) 1, biomarker

    Received: 19 Jul 2024; Accepted: 05 Nov 2024.

    Copyright: © 2024 Guo, Shao, Wang, Zhou and Duan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xinwang Duan, Second Affiliated Hospital of Nanchang University, Nanchang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.